anayamalik, Author at European Medical Journal - Page 90 of 96

Lupus in Pregnancy Linked to Placental Damage

Systemic lupus erythematosus impacts placental health, particularly in pregnancies resulting in small for gestational age infants.

CDC Warns of Rising Pneumonia and RSV in Children

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

Ketamine Treatment for Bipolar Shows Full Remission

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.

Can Diet Quality Slow Prostate Cancer?

Diet quality could play a role in the progression of prostate cancer for men undergoing active surveillance.

Advanced Lung Cancer Wearable Receives FDA Approval

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

Race and Socioeconomic Factors Reveal Low Vaccine Rates: IDWeek 2024

Vaccination rates in the U.S. continue to lag, and new research presented at IDWeek 2024 in Los Angeles, California, underscored the role social vulnerabilities play in access to preventive healthcare.

24-Hour Therapy for Parkinson’s: The First Of Its Kind

The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease. This therapy is the first of its kind.

Pre-Exposure Prophylaxis Uptake Across US: IDWeek 2024

Use of pre-exposure prophylaxis (PrEP), an HIV-1 prevention strategy, across diverse demographic groups is not consistent, despite importance of the tool.

National Trends in Sepsis Rates in Children: IDWeek 2024

New data presented at IDWeek 2024, October 16-19, alerted doctors about the national trends and racial disparities in sepsis-related mortality rates (SRMR) in children between 1999 to 20219.

How Do Extreme Temperatures Affect Raynaud’s Phenomenon?

Hot and cold outdoor temperatures significantly worsen Raynaud’s phenomenon in patients with systemic sclerosis, according to new research.